These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16002741)

  • 1. Rho-kinase is an important therapeutic target in cardiovascular medicine.
    Shimokawa H; Takeshita A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress of the study of rho-kinase and future perspective of the inhibitor.
    Tawara S; Shimokawa H
    Yakugaku Zasshi; 2007 Mar; 127(3):501-14. PubMed ID: 17329936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Rho-kinase inhibitors for cardiovascular medicine.
    Shimokawa H; Rashid M
    Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
    Budzyn K; Marley PD; Sobey CG
    Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.
    Hu E; Lee D
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1065-75. PubMed ID: 14582450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling].
    Jalil J; Lavandero S; Chiong M; Ocaranza MP
    Rev Esp Cardiol; 2005 Aug; 58(8):951-61. PubMed ID: 16053829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent effects of estrogen and nicotine on Rho-kinase expression in human coronary vascular smooth muscle cells.
    Hiroki J; Shimokawa H; Mukai Y; Ichiki T; Takeshita A
    Biochem Biophys Res Commun; 2005 Jan; 326(1):154-9. PubMed ID: 15567165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells.
    Hiroki J; Shimokawa H; Higashi M; Morikawa K; Kandabashi T; Kawamura N; Kubota T; Ichiki T; Amano M; Kaibuchi K; Takeshita A
    J Mol Cell Cardiol; 2004 Aug; 37(2):537-46. PubMed ID: 15276023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm.
    Kandabashi T; Shimokawa H; Miyata K; Kunihiro I; Eto Y; Morishige K; Matsumoto Y; Obara K; Nakayama K; Takahashi S; Takeshita A
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2209-14. PubMed ID: 14592852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells.
    Nakakuki T; Ito M; Iwasaki H; Kureishi Y; Okamoto R; Moriki N; Kongo M; Kato S; Yamada N; Isaka N; Nakano T
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2088-93. PubMed ID: 16123329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
    Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans.
    Calò LA; Pessina AC
    J Hypertens; 2007 Feb; 25(2):259-64. PubMed ID: 17211228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases.
    Shimokawa H
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):319-27. PubMed ID: 11862109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular protective action of Rho-kinase inhibitors].
    Hirooka Y
    Nihon Rinsho; 2004 Jan; 62(1):161-71. PubMed ID: 14737849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rho-Rho kinase pathway].
    Takuwa Y
    Nihon Rinsho; 2004 Jan; 62(1):43-8. PubMed ID: 14737834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rho and Rho-kinase].
    Sato J; Iiri T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():197-202. PubMed ID: 16897863
    [No Abstract]   [Full Text] [Related]  

  • 20. Rho/Rho-kinase mediated signaling in physiology and pathophysiology.
    Wettschureck N; Offermanns S
    J Mol Med (Berl); 2002 Oct; 80(10):629-38. PubMed ID: 12395147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.